A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049] |
Dickler, Maura |
|
A Phase I Study of AT13387 Alone or with Abiraterone to Treat Castration-Resistant Prostate Cancer that Continues Growing Despite Abiraterone
[Protocol 12-248] |
Slovin, Susan |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255] |
Voss, Martin |
|
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170] |
Paik, Paul |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151] |
Dunkel, Ira |
|
A Phase I Study of BI 836858 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-133] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233] |
Bell-McGuinn, Katherine |
- Breast Cancer
- Ovarian Cancer
|
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192] |
Fury, Matthew |
|
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of BMS-663513 (Anti-CD137 Antibody) in Patients with Advanced or Metastatic Solid Tumors
[Protocol 11-212] |
Segal, Neil |
|
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
- Lymphoma
|
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
[Protocol 12-142] |
Lesokhin, Alexander |
- Hematology
- Leukemia
- Chronic Myelocytic Leukemia
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Phase I Study of Brentuximab Vedotin plus Temsirolimus in Relapsed and Refractory Hodgkin Lymphoma
[Protocol 13-044] |
Moskowitz, Alison |
|
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027] |
Dickler, Maura |
|
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] |
Trippett, Tanya |
- Pediatric Brain Tumors
- Primary Bone
- Sarcomas
- Solid Tumors
|
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106] |
Bell-McGuinn, Katherine |
|
A Phase I Study of Carboxyamidotriazole Orotate Plus Temozolomide in Patients with Glioblastoma Multiforme and Other Recurrent Malignant Gliomas
[Protocol 12-007] |
Omuro, Antonio |
|
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048] |
Park, Jae |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011] |
Souweidane, Mark |
|
